Dolby Laboratories, Inc.
Dolby Laboratories, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Class A | -1 | 61 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | |||||
Common Class B | -0 | 35 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 594 | 644 | 702 | 699 | 627 | 521 | 482 | 742 | 710 | 657 | 745 | 765 | |||||
Restricted Cash And Cash Equivalents | 80 | 84 | 91 | 58 | 124 | 91 | 96 | 37 | 115 | 52 | 73 | 34 | |||||
Short Term Investments | 0 | 1 | 1 | 1 | - | - | 0 | 127 | 116 | 141 | 139 | 124 | |||||
Accounts Receivable Net Current | 391 | 373 | 331 | 298 | 314 | 339 | 315 | 286 | 282 | 293 | 262 | 267 | |||||
Contract With Customer Asset Net Current | - | - | 181 | - | - | - | 197 | - | - | - | 182 | - | |||||
Contract With Customer Asset Net | 239 | 198 | - | 204 | 230 | 221 | - | 191 | 243 | 218 | - | 193 | |||||
Inventory Net | 32 | 31 | 30 | 32 | 35 | 32 | 34 | 35 | 36 | 38 | 36 | 32 | |||||
Prepaid Expense And Other Assets Current | 78 | 77 | 52 | 46 | 60 | 82 | 70 | 51 | 50 | 54 | 51 | 54 | |||||
Assets Current | 1,415 | 1,408 | 1,388 | 1,338 | 1,389 | 1,286 | 1,194 | 1,469 | 1,552 | 1,451 | 1,488 | 1,469 | |||||
Long Term Investments | 81 | 85 | 80 | 78 | 74 | 86 | 89 | 118 | 128 | 93 | 98 | 98 | |||||
Property Plant And Equipment Net | 462 | 467 | 471 | 478 | 473 | 476 | 479 | 478 | 481 | 479 | 482 | 502 | |||||
Operating Lease Right Of Use Asset | 45 | 36 | 33 | 33 | 34 | 37 | 39 | 40 | 43 | 38 | 40 | 39 | |||||
Intangible Assets Net Excluding Goodwill | 390 | 364 | 397 | 408 | 412 | 421 | 435 | 145 | 152 | 160 | 167 | 177 | |||||
Goodwill | 530 | 530 | 530 | 529 | 525 | 520 | 533 | 408 | 409 | 410 | 408 | 426 | |||||
Other Assets Noncurrent | 118 | 88 | 114 | 103 | 99 | 105 | 121 | 97 | 71 | 97 | 95 | 86 | |||||
Deferred Income Tax Assets Net | 209 | 214 | 214 | 229 | 223 | 227 | 220 | 220 | 208 | 207 | 202 | 210 | |||||
Assets | 3,249 | 3,192 | 3,228 | 3,196 | 3,229 | 3,159 | 3,110 | 2,974 | 3,045 | 2,936 | 2,980 | 3,008 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 21 | 9 | 18 | 17 | 17 | 12 | 17 | 16 | 20 | 14 | 21 | 15 | |||||
Accrued Liabilities Current | 405 | 376 | 369 | 317 | 376 | 361 | 348 | 281 | 363 | 327 | 351 | 347 | |||||
Accrued Income Taxes Current | 0 | 11 | 9 | 7 | 13 | 21 | 9 | 12 | 8 | 6 | 5 | 11 | |||||
Contract With Customer Liability Current | 39 | 37 | 31 | 36 | 40 | 37 | 32 | 33 | 38 | 33 | 32 | 37 | |||||
Operating Lease Liability Current | 10 | 10 | 10 | 11 | 11 | 11 | 12 | 13 | 14 | 13 | 14 | 14 | |||||
Liabilities Current | 475 | 444 | 438 | 389 | 457 | 442 | 418 | 355 | 443 | 394 | 422 | 423 | |||||
Contract With Customer Liability Noncurrent | 24 | 25 | 30 | 29 | 30 | 32 | 35 | 36 | 36 | 37 | 40 | 42 | |||||
Operating Lease Liability Noncurrent | 40 | 30 | 28 | 28 | 30 | 33 | 35 | 36 | 38 | 34 | 37 | 37 | |||||
Other Liabilities Noncurrent | 84 | 90 | 100 | 136 | 129 | 134 | 136 | 100 | 90 | 108 | 108 | 124 | |||||
Liabilities | 622 | 589 | 596 | 582 | 646 | 642 | 623 | 526 | 607 | 573 | 608 | 625 | |||||
Stockholders Equity | |||||||||||||||||
Retained Earnings Accumulated Deficit | 2,630 | 2,604 | 2,635 | 2,618 | 2,602 | 2,543 | 2,496 | 2,463 | 2,450 | 2,367 | 2,392 | 2,397 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -12 | -11 | -13 | -14 | -28 | -36 | -19 | -30 | -29 | -21 | -37 | -31 | |||||
Stockholders Equity | 2,627 | 2,603 | 2,632 | 2,605 | 2,574 | 2,508 | 2,477 | 2,433 | 2,421 | 2,362 | 2,372 | 2,366 | |||||
Minority Interest | 9 | 9 | 9 | 10 | 9 | 9 | 10 | 15 | 17 | 16 | 17 | 16 | |||||
Liabilities And Stockholders Equity | 3,249 | 3,192 | 3,228 | 3,196 | 3,229 | 3,159 | 3,110 | 2,974 | 3,045 | 2,936 | 2,980 | 3,008 | |||||
Allowance For Doubtful Accounts Receivable Current | 10 | 8 | 7 | 7 | 7 | 6 | 5 | 5 | 6 | 7 | 10 | 10 | |||||
Contract With Customer Asset Accumulated Allowance… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 2.06% | -3.76% | 3.11% | -14.17% | -17.90% | -23.01% | - | - | - | - | - | - |
| 2025 | -6.22% | -7.12% | -17.26% | -1.56% | -4.71% | -0.67% | 0.84% | -4.55% | -8.33% | 4.53% | -0.41% | 0.37% |
| 2024 | 0.04% | 4.69% | -2.23% | 0.36% | 0.72% | -0.66% | -2.13% | 3.70% | -0.17% | 12.12% | 8.14% | 18.75% |
| 2023 | - | - | - | -2.73% | -4.13% | 5.19% | -4.47% | -7.19% | -8.74% | 9.96% | 3.73% | -1.26% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.98 | 3.17 | 3.17 | 3.44 | 3.04 | 2.91 | 2.86 | 4.14 | 3.50 | 3.68 | 3.52 | 3.47 | |||||
| Quick Ratio | 2.75 | 2.93 | 2.98 | 3.24 | 2.83 | 2.65 | 2.61 | 3.90 | 3.31 | 3.45 | 3.32 | 3.27 | |||||
| Working Capital | 940.10M | 964.56M | 950.47M | 949.33M | 931.80M | 843.92M | 776.58M | 1.11B | 1.11B | 1.06B | 1.07B | 1.05B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.24 | 0.23 | 0.23 | 0.22 | 0.25 | 0.26 | 0.25 | 0.22 | 0.25 | 0.24 | 0.26 | 0.26 | |||||
| Interest Coverage TTM | - | - | - | - | - | - | - | - | 1,645.88 | 1,269.50 | 942.15 | 669.44 | |||||
| Debt Ratio | 0.19 | 0.18 | 0.18 | 0.18 | 0.20 | 0.20 | 0.20 | 0.18 | 0.20 | 0.20 | 0.20 | 0.21 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.42 | 0.42 | 0.43 | 0.44 | 0.42 | 0.43 | 0.42 | 0.42 | 0.43 | 0.45 | 0.46 | 0.43 | |||||
| Days Sales Outstanding TTM | 94.32 | 97.11 | 87.46 | 79.06 | 82.42 | 87.78 | 82.77 | 80.09 | 81.32 | 83.07 | 71.03 | 71.32 | |||||
| Receivables Turnover TTM | 3.87 | 3.76 | 4.17 | 4.62 | 4.43 | 4.16 | 4.41 | 4.56 | 4.49 | 4.39 | 5.14 | 5.12 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 2.56 | 2.50 | 2.63 | 2.72 | 2.63 | 2.70 | 2.69 | 2.22 | 1.99 | 1.95 | 2.06 | 2.25 | |||||
| Free Cash Flow Per Share TTM | 3.17 | 4.04 | 4.55 | 4.57 | 4.05 | 4.13 | 3.11 | 2.77 | 3.82 | 3.04 | 3.52 | 3.14 | |||||
| Dividend Per Share TTM | 1.39 | 1.36 | 1.32 | 1.29 | 1.25 | 1.23 | 1.20 | 1.17 | 1.14 | 1.11 | 1.08 | 1.06 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 87.44% | 87.86% | 88.13% | 88.52% | 88.92% | 88.65% | 88.97% | 88.72% | 88.35% | 88.27% | 88.26% | 88.02% | |||||
| Operating Profit Margin TTM | 18.49% | 18.47% | 19.64% | 20.91% | 20.51% | 20.68% | 20.28% | 16.55% | 14.79% | 14.67% | 16.60% | 19.14% | |||||
| Net Profit Margin TTM | 17.91% | 18.06% | 19.01% | 19.54% | 19.42% | 19.95% | 20.56% | 17.11% | 15.15% | 14.82% | 15.51% | 17.05% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 3.39% | 1.80% | 5.92% | 6.94% | 4.03% | 2.71% | -2.00% | -2.17% | -0.75% | 3.50% | 3.66% | 2.12% | |||||
| Net Income Growth (1Y) | -4.64% | -7.84% | -2.04% | 22.12% | 33.30% | 38.22% | 29.85% | -1.80% | -20.77% | 3.41% | 9.54% | 9.56% | |||||
| EPS Growth (1Y) | -3.53% | -7.70% | -2.37% | 21.85% | 32.45% | 37.88% | 30.15% | -1.83% | -20.68% | 3.98% | 14.36% | 14.78% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 23.25 | 25.07 | 26.59 | 26.48 | 29.41 | 27.63 | 26.99 | 33.86 | 39.99 | 41.38 | 35.85 | 34.60 | |||||
| P/B TTM | 2.16 | 2.33 | 2.59 | 2.68 | 2.93 | 2.89 | 2.84 | 3.00 | 3.18 | 3.32 | 3.05 | 3.21 | |||||
| P/S TTM | 4.16 | 4.53 | 5.06 | 5.17 | 5.71 | 5.51 | 5.55 | 5.79 | 6.06 | 6.13 | 5.56 | 5.90 | |||||
| Market Cap | 5.68B | 6.06B | 6.82B | 6.97B | 7.54B | 7.25B | 7.07B | 7.30B | 7.69B | 7.85B | 7.23B | 7.60B | |||||
| Enterprise Value | 5.01B | 5.33B | 6.03B | 6.21B | 6.79B | 6.64B | 6.49B | 6.52B | 6.87B | 7.15B | 6.41B | 6.80B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 301.47M | 386.02M | 435.85M | 438.05M | 390.44M | 394.94M | 297.25M | 265.28M | 365.35M | 289.87M | 336.74M | 300.51M | |||||
| Net Debt | -673.81M | -727.57M | -793.36M | -756.56M | -750.34M | -611.66M | -577.75M | -778.62M | -824.36M | -708.66M | -817.97M | -799.16M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Dolby Laboratories, Inc. (DLB) — SEC Financial Statements & Analysis
Dolby Laboratories, Inc. (DLB) is a patent owners & lessors company, incorporated in DE. Dolby Laboratories, Inc. trades on NYSE as: DLB. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Dolby Laboratories, Inc. reported a 3.39% year-over-year revenue growth, a Gross Profit Margin of 87.44% (TTM), a Debt-to-Equity ratio of 0.24x, a Price-to-Sales (P/S) ratio of 4.16x (TTM), a Price-to-Book (P/B) ratio of 2.16 (TTM), at a market cap of $5.68B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 3.39%
- Gross Profit Margin TTM
- 87.44%
- Debt To Equity
- 0.24x
- P/S TTM
- 4.16x
- P/B TTM
- 2.16
- Market Cap
- $5.68B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Dolby Laboratories, Inc. in?
Dolby Laboratories, Inc. (DLB) operates in the Patent Owners & Lessors industry.
What is DLB's market cap?
Dolby Laboratories, Inc. (DLB) has a market capitalization of $5.68B as of 2026-03-31.
What is DLB's P/E ratio?
Dolby Laboratories, Inc. (DLB)'s trailing twelve month P/E ratio is 23.25x as of 2026-03-31.
What exchange does DLB trade on?
Dolby Laboratories, Inc. (DLB) trades on the NYSE.
Where is Dolby Laboratories, Inc. incorporated?
Dolby Laboratories, Inc. is incorporated in DE.